3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Neoplasms
3
Lymphoma
3
Preleukemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphoid
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Leukemia
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Esophageal Neoplasms
2
Bone Marrow Diseases
2
Sarcoma
1
Primary Myelofibrosis
1
Pathologic Complete Response
1
Osteosarcoma
1
Neoplasms, Second Primary
1
Neoplasms, Plasma Cell
1
Interventions
pembrolizumab
4
lenvatinib
3
Magnetic Resonance Spectroscopy
3
Specimen Handling
2
Nivolumab
2
Epirubicin
2
regorafenib
1
gallium 68 PSMA-11
1
enfortumab vedotin
1
anlotinib
1
amivantamab
1
abemaciclib
1
Tablets
1
Surveys and Questionnaires
1
Standard of Care
1
Radiosurgery
1
Pemetrexed
1
Observation
1
Ipilimumab
1
Imatinib Mesylate
1
Glutamate Carboxypeptidase II
1
Cyclophosphamide
1
Combined Modality Therapy
1
Carboplatin
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
BMS-906024
1
68Ga-DKFZ-PSMA-11
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Adenoid Cystic
×
Patient Reported Outcome Measures
×
1 year
×
Clear all
No trials found.